Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Margaret Guy, MD, Lauren Magee, PharmD, BCPS, Jessica Keiser, MD, Nicole Carter, RN, MSN, NP-C, DaleMarie Vaughan, PharmD, BCPS, Chantal McHenry, BS, Daniel Sop, BS,MS, Sarah Hartigan, MD, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 3446.

https://doi.org/10.1182/blood-2019-131298

Published: 2019

Journal Articles

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

Luke Mountjoy, DO, Daniel Almquist, MD, Henry Ofori, Pharm D, RPh, Marlene Girardo, MS, Margaret McCallen, Pharm D, RPh

Blood (2019) 134 (Supplement_1): 3262.

https://doi.org/10.1182/blood-2019-128644

Published: 2019

Journal Articles

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

Wallace Jones, MD, Leann Myers, Aditi Dasgupta, Jessica Debord

Blood (2019) 134 (Supplement_1): 3383.

https://doi.org/10.1182/blood-2019-127097

Published: 2019

Journal Articles

Opioid Utilization in Adults Hospitalized with Sickle Cell Pain Crises: An Understudied Population

Angie Mae Rodday, PhD, Kimberly S Esham, MD, Nicole S Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 5884.

https://doi.org/10.1182/blood-2018-99-111386

Published: 2018

Journal Articles

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization

Craig W. Freyer, PharmD, Alex Ganetsky, PharmD, Colleen Timlin, PharmD, Daria V. Babushok, MD PhD, Noelle V. Frey, MD, Saar I. Gill, MD PhD, Elizabeth O. Hexner, MD MS, Alison W. Loren, MD MS, James K. Mangan, MD PhD, Mary Ellen Martin, MD, Shannon R. McCurdy, MD, Alexander E. Perl, MD, Selina Luger, MD, Jacqueline Smith, MSN, CRNP, Edward Stadtmauer, David L. Porter, MD

Blood (2018) 132 (Supplement 1): 5696.

https://doi.org/10.1182/blood-2018-99-111550

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Gunjan L. Shah, MD, Heather Landau, MD, Caitlin Sarubbi, A.B, Ryan Schofield, MS, Andrew Lin, PharmD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Sean M. Devlin, PhD, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD

Blood (2017) 130 (Supplement 1): 3296.

https://doi.org/10.1182/blood.V130.Suppl_1.3296.3296

Published: 2017

Journal Articles

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah, MD, Andrew Lin, PharmD, Ryan Schofield, MS, Caitlin Sarubbi, AB, Elaina V. Preston, PA-C,MPH, Sean M. Devlin, PhD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Elizabeth Hoover, BS, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD, Heather Landau, MD

Blood (2017) 130 (Supplement 1): 2023.

https://doi.org/10.1182/blood.V130.Suppl_1.2023.2023

Published: 2017

Journal Articles

Understanding Sleep in Pediatric Patients with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Crisis through Objective Data

Kalindi Narine, MD, Fan Yang, Tanvi Banerjee, Jude Jonassaint, Nirmish Shah, MD

Blood (2017) 130 (Supplement 1): 4791.

https://doi.org/10.1182/blood.V130.Suppl_1.4791.4791

Published: 2017

Journal Articles

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Paul S Martin, MD, Elahe Mostaghel, MD PhD, Stephen Mongovin, Shani L. Frayo, Ailin Zhang, Kerstin Lara Edlefsen, MD, Oliver W Press, MD PhD, Ajay K. Gopal, MD

Blood (2016) 128 (22): 3014.

https://doi.org/10.1182/blood.V128.22.3014.3014

Published: 2016

Journal Articles

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Xiao-Yan Zhao, PhD, Subramanian Yegneswaran, PhD, Maxine Bauzon, Derek Sim, Chandra Patel, PhD, Doug Schneider, Kirk McLean, Ying Zhu, MD, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, PhD, Inge Ivens, PhD, Jun Xu, PhD, Peter Wolfgang Bringmann, PhD, Katalin Kauser, Charles Esmon, PhD

Blood (2016) 128 (22): 80.

https://doi.org/10.1182/blood.V128.22.80.80

Published: 2016

Journal Articles

Lower Continuous Infusion, Higher Bolus Dose Patient-Controlled Analgesia Results in Shorter Hospitalization in Children with Sickle Cell Vaso-Occlusive Pain Crisis

Tabetha Todd, PharmD, Jonica Huntman, PharmD, Gianna W. Sparks, Monica L. Hulbert, MD

Blood (2015) 126 (23): 523.

https://doi.org/10.1182/blood.V126.23.523.523

Published: 2015

Journal Articles

Opioid Prescription Practices at Discharge and 30-Day Returns in Children with Sickle Cell Disease and Pain

Leslie M Okorji, BS, Devin S Muntz, BS, Robert I Liem, MD MS

Blood (2015) 126 (23): 3417.

https://doi.org/10.1182/blood.V126.23.3417.3417

Published: 2015

Journal Articles

Benefits of Patient-Controlled Analgesia without Continuous Infusion for the Treatment of Sickle Cell Disease Vaso-Occlusive Crisis Pain

Veronica Carullo, MD, Meagan Murphy, PNP, Jaeun Choi, PhD, Qi Gao, PhD, Catherine Driscoll, MD, Deepa Manwani, MD

Blood (2015) 126 (23): 3398.

https://doi.org/10.1182/blood.V126.23.3398.3398

Published: 2015

Journal Articles

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Vinita Gupta, MD, Hulya Armutlugoynuk, MD, Anant Vatsayan, MD MBBS, Paolo F. Caimi, MD, Brenda Cooper, MD, Leland Metheny, MD, Ehsan Malek, MD, Erica L. Campagnaro, MD, Stan Gerson, MD, Marcos de Lima, MD, Hillard M. Lazarus, MD, Richard J Creger, PharmD

Blood (2015) 126 (23): 5491.

https://doi.org/10.1182/blood.V126.23.5491.5491

Published: 2015

Journal Articles

Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit

Taylor Mueller, BS, LaShon Sturgis, MD PhD, Patrick Loeffler, BS, Ann-Marie Kuckinski, PhD, Abdullah Kutlar, MD, Robert Gibson, PhD, Matthew Lyon, MD

Blood (2015) 126 (23): 5568.

https://doi.org/10.1182/blood.V126.23.5568.5568

Published: 2015

Journal Articles

Implementation of a Community Hospital-Based Fast Track Pathway for the Treatment of Acute Pain Episodes in Adults with Sickle Cell Disease

Richard Lottenberg, MD, Robert Krywicki, MD, Gurinder Doad, MD, Witemba Kabange, MD, Monisola Modupe, MD, Gregory Steele, APRN, Zerettia K McGriff, RN,BS, James A Sirleaf, MD, Abdullah Kutlar, MD, Robert Gibson, PhD, Betsy Clair, Matthew L Lyon, MD

Blood (2014) 124 (21): 4854.

https://doi.org/10.1182/blood.V124.21.4854.4854

Published: 2014

Journal Articles

Stability Of Thrombin Generation In Cirrhotic Patients

Thomas Sinegre, PharmD, Armand Abergel, MD, PhD, Géraldine Lamblin, MD, Marc G Berger, MD, PhD, Aurélien Lebreton, MD, PhD

Blood (2013) 122 (21): 2361.

https://doi.org/10.1182/blood.V122.21.2361.2361

Published: 2013

Journal Articles

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

Laura M. De Castro, MD, Ted Wun, MD, Sophie Lanzkron, MD MHS, Wally R. Smith, MD, Kathryn L. Hassell, MD, Abdullah Kutlar, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 775.

https://doi.org/10.1182/blood.V122.21.775.775

Published: 2013

Journal Articles

Safety and Efficacy of Adjuvant Low-Dose Ketamine Therapy for Patients with Sickle Cell Disease

Caitlin M. Neri, M.D., M.P.H. Candidate, Sophie Pestieau, M.D., Heather Young, Ph.D., M.P.H., C.H.E.S., Angelo Elmi, Ph.D., Deepika S. Darbari, M.D.

Blood (2012) 120 (21): 3226.

https://doi.org/10.1182/blood.V120.21.3226.3226

Published: 2012

NARROW

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

Opioid Utilization in Adults Hospitalized with Sickle Cell Pain Crises: An Understudied Population

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Understanding Sleep in Pediatric Patients with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Crisis through Objective Data

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Lower Continuous Infusion, Higher Bolus Dose Patient-Controlled Analgesia Results in Shorter Hospitalization in Children with Sickle Cell Vaso-Occlusive Pain Crisis

Opioid Prescription Practices at Discharge and 30-Day Returns in Children with Sickle Cell Disease and Pain

Benefits of Patient-Controlled Analgesia without Continuous Infusion for the Treatment of Sickle Cell Disease Vaso-Occlusive Crisis Pain

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit

Implementation of a Community Hospital-Based Fast Track Pathway for the Treatment of Acute Pain Episodes in Adults with Sickle Cell Disease

Stability Of Thrombin Generation In Cirrhotic Patients

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

Safety and Efficacy of Adjuvant Low-Dose Ketamine Therapy for Patients with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only